Blanke C - Search Results

1

Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group Trial 1597.

Masters GA, Declerck L, Blanke C, Sandler A, DeVore R, Miller K, Johnson D; Eastern Cooperative Oncology Group. Masters GA, et al. Among authors: blanke c. J Clin Oncol. 2003 Apr 15;21(8):1550-5. doi: 10.1200/JCO.2003.09.130. J Clin Oncol. 2003. PMID: 12697880 Clinical Trial.

2

Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol.

Blanke C, Ansari R, Mantravadi R, Gonin R, Tokars R, Fisher W, Pennington K, O'Connor T, Rynard S, Miller M, et al. Blanke C, et al. J Clin Oncol. 1995 Jun;13(6):1425-9. doi: 10.1200/JCO.1995.13.6.1425. J Clin Oncol. 1995. PMID: 7751888 Clinical Trial.

3

Combined modality therapy in non-small cell lung cancer.

Blanke CD, Johnson DH. Blanke CD, et al. Curr Opin Oncol. 1995 Mar;7(2):144-9. doi: 10.1097/00001622-199503000-00009. Curr Opin Oncol. 1995. PMID: 7756379 Review.

4

Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial.

Johnson DH, Paul DM, Hande KR, Shyr Y, Blanke C, Murphy B, Lewis M, De Vore RF 3rd. Johnson DH, et al. Among authors: blanke c. J Clin Oncol. 1996 Jul;14(7):2054-60. doi: 10.1200/JCO.1996.14.7.2054. J Clin Oncol. 1996. PMID: 8683236 Clinical Trial.

5

A pilot study of protracted low dose cisplatin and etoposide with concurrent thoracic radiotherapy in unresectable stage III nonsmall cell lung cancer.

Blanke C, DeVore R, Shyr Y, Epstein B, Murray M, Hande K, Stewart S, Johnson D. Blanke C, et al. Int J Radiat Oncol Biol Phys. 1997 Jan 1;37(1):111-6. doi: 10.1016/s0360-3016(96)00478-6. Int J Radiat Oncol Biol Phys. 1997. PMID: 9054884 Clinical Trial.

6

Treatment of small cell lung cancer.

Blanke CD, Johnson DH. Blanke CD, et al. Semin Thorac Cardiovasc Surg. 1997 Jan;9(1):101-10. Semin Thorac Cardiovasc Surg. 1997. PMID: 9109230 Review.

7

CODE (cisplatin, vincristine, doxorubicin, etoposide) plus granulocyte colony-stimulating factor in advanced non-small-cell lung cancer: a Hoosier Oncology Group phase II trial.

Sandler A, Blanke C, Monaco F, Carey MA, Ansari R, Fisher B, Spiridonidis CH, Einhorn L, Nichols C. Sandler A, et al. Among authors: blanke c. Am J Clin Oncol. 1998 Jun;21(3):294-7. doi: 10.1097/00000421-199806000-00019. Am J Clin Oncol. 1998. PMID: 9626802 Clinical Trial.

8

Paclitaxel, UFT, and calcium folinate in metastatic breast cancer.

Dickson NR, Nicholson BP, Hande K, Blanke C, Johnson D, Cohen A. Dickson NR, et al. Among authors: blanke c. Oncology (Williston Park). 1999 Jul;13(7 Suppl 3):69-70. Oncology (Williston Park). 1999. PMID: 10442366 Free article. Clinical Trial.

9

Phase II study of the multitargeted antifolate LY231514 (ALIMTA, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer.

Miller KD, Picus J, Blanke C, John W, Clark J, Shulman LN, Thornton D, Rowinsky E, Loehrer PJ Sr. Miller KD, et al. Among authors: blanke c. Ann Oncol. 2000 Jan;11(1):101-3. doi: 10.1023/a:1008305205159. Ann Oncol. 2000. PMID: 10690396 Free article. Clinical Trial.

10

A phase I study of vitamin E, 5-fluorouracil and leucovorin for advanced malignancies.

Blanke CD, Stipanov M, Morrow J, Rothenberg M, Chinery R, Shyr Y, Coffey R, Johnson DH, Leach SD, Beauchamp RD. Blanke CD, et al. Invest New Drugs. 2001;19(1):21-7. doi: 10.1023/a:1006484031959. Invest New Drugs. 2001. PMID: 11291830 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters